Login
search
Contact Us

Gray Matters from Epilepsia

Epilepsia

2016 Gray Matters

January

  • Letters:
    • The relevance of “diagnostic delay” in epilepsy
    • Reproductive disorders in patients with epilepsy; we need high quality studies
  • Announcements

2015 Gray Matters

December

  • Announcements

November

  • Letter and Response: LQT, HCN, and epilepsy model
  • Announcements

October

  • Announcements

September

  • Letters and Responses
    • Beyond and within CA1 subfield in magnetic resonance imaging negative temporal lobe epilepsy
    • In response: From the CA1 subfield, and beyond!
    • Evaluating the care of a multidisciplinary clinic by using the White Paper “Listening for a change: Medical and social needs of people with intellectual disability who have epilepsy”
    • In response: Evaluating the care of a multidisciplinary clinic by using the White Paper “Listening for a change: Medical and social needs of people with intellectual disability who have epilepsy”
  • Announcements

August

  • Letters and Responses
    • Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017
    • Naming and recognition after laser amygdalohippocampotomy: Is the hippocampus involved?
    • SCN8A mutations in Chinese children with early onset epilepsy and intellectual disability
    • Epilepsy surgery trends in the United States: Differences between children and adults
  • Announcements

July

  • Letters
    • Valproate still has a place in women with epilepsy
    • Commentary on long-term seizure outcome in 211 patients with focal cortical dysplasia
    • In response: Long-term seizure outcome in 211 patients with focal cortical dysplasia
    • Why should we change the term psychogenic nonepileptic seizures?
    • In Response: Terminology of psychogenic nonepileptic seizures—a Babel of different names?
    • Cav2.3 R-type Ca2+ channels in anticonvulsive treatment
    • In response: Cav2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo
    • Sertraline-carbamazepine neurotoxic interaction: Fiction or fact?
  • Announcements

June

  • Letters
    • Multifactorial basis of epilepsy in patients with neurocysticercosis; response
    • Talairach methodology in the era of 3D multimodal imaging: “The song remains the same,” but catchier, and therefore more helpful for clinical decision making and surgical planning in epilepsy surgery; response
    • The terminology of psychogenic nonepileptic seizures: a historical perspective
    • In response: Terminology of PNES over time—the terms they are a-changin’
  • Announcements

May

  • Invitation to participate in the EpiNet-First trials
  • Letters
    • Long-term outcome in children with infantile spasms treated with vigabatrin: A cohort of 180 patients
    • In response to: Long-term outcome in children with infantile spasms treated with vigabatrin: A cohort of 180 patients
  • Announcements

April

  • Letters:
    • Undue regulatory control on phenobarbital — an important yet overlooked reason for the epilepsy treatment gap
    • Recruitment of patients with both epilepsy and intellectual disability
  • Announcements

March

  • Letter and response:
    • Lennox-Gastaut syndrome may be a curable, reversible epileptic encephalopathy
  • Announcements

February

  • Workshop report: Michael Foundation Forum2014, Bonn, Germany
  • Letters:
    • Nonadherence to treatment causing acute hospitalizations in people with epilepsy
      • In response: Nonadherence to treatment causing acute hospitalizations in people with epilepsy: An observational, prospective study
    • Research using archival health care data: Let the buyer beware
      • In response: Research using archival health care data: Let the buyer beware
    • Vagus nerve stimulation for epilepsy treatment in children
      • In response: Vagus nerve stimulation for epilepsy treatment in children
  • Announcements

January

  • Announcements

 

Home | Contact Us | Privacy & Security | Login | Sitemap
Creative Commons License
Text on this website is available under a
Creative Commons Attribution-ShareAlike 4.0 International License
except all videos and images, which remain copyrighted by the International League Against Epilepsy.